Skip to main content
GRML
NASDAQ Life Sciences

Greenland Mines Secures $3.75M in Private Placement at Deep Discount

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.319
Mkt Cap
$38.712M
52W Low
$0.21
52W High
$1.67
52W Position info
52% above low
Off High info
81% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

GRML sits 52% above its 52-week low of $0.21.

Summary

Greenland Mines Ltd. raised $3.75 million by selling 15 million shares at a 21.6% discount to market price, providing critical working capital amidst financial distress and upcoming corporate actions.


Key Events · Financing and Capital Events · GRML

  • Private Placement Secured

    The company entered into a Securities Purchase Agreement on June 15, 2026, to sell 15,000,000 shares of common stock to three investors.

  • Capital Raised

    The offering will generate total proceeds of $3,750,000 for the company.

  • Deep Discount Pricing

    Shares were sold at $0.25 per share, representing a 21.6% discount to the current market price of $0.3193.

  • Use of Proceeds

    Funds are designated for working capital and general corporate purposes, critical for the company's operations.


Analysis · GRML · Life Sciences

Greenland Mines Ltd. has secured $3.75 million through a private placement, selling 15 million shares at $0.25 each, a significant discount to its current trading price. This capital infusion is crucial for working capital and general corporate purposes, especially given the company's ongoing financial distress, going concern doubts, and recent large acquisition. The deep discount reflects the urgency of the capital raise and will result in substantial dilution for existing shareholders.

How filings like this one have moved

In the 30 days to Oct 29, 2026, 38.8% of the 970 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.46%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, GRML was trading at $0.32 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $38.7M. The 52-week trading range was $0.21 to $1.67. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GRML - Latest Insights

GRML
Oct 06, 2026, 9:15 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $7.66
Real-time Price: $5.15 info
Change: -$2.51 (-33%) info
Market Cap: $70.459M info
GRML
Oct 05, 2026, 8:45 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $8.45
Real-time Price: $5.15 info
Change: -$3.30 (-39%) info
Market Cap: $70.459M info
GRML
Sep 29, 2026, 8:35 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $10.68
Real-time Price: $5.15 info
Change: -$5.53 (-52%) info
Market Cap: $70.459M info
GRML
Sep 28, 2026, 4:53 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $11.68
Real-time Price: $5.15 info
Change: -$6.53 (-56%) info
Market Cap: $70.459M info
GRML
Sep 28, 2026, 4:43 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $11.80
Real-time Price: $5.15 info
Change: -$6.65 (-56%) info
Market Cap: $70.459M info